Emily’s Entourage is an innovative 501(c)3 foundation that accelerates research and drug development for the final 10% of people with cystic fibrosis (CF), including those with nonsense mutations. By providing critical leadership and coordination, Emily’s Entourage drives high-impact research, cultivates multi-stakeholder collaboration, and facilitates information exchange to speed breakthroughs. Since 2011, Emily's Entourage has awarded millions of dollars in research grants, launched a CF gene therapy company recently acquired by a large pharmaceutical company, and led worldwide efforts to drive high-impact research and drug development. The organization has been featured in national media, including the New York Times, STAT, CNN, People, and more.
Emily’s Entourage is an innovative 501(c)3 foundation that accelerates research and drug development for the final 10% of people with cystic fibrosis (CF), including those with nonsense mutations. By providing critical leadership and coordination, Emily’s Entourage drives high-impact research, cultivates multi-stakeholder collaboration, and facilitates information exchange to speed breakthroughs. Since 2011, Emily's Entourage has awarded millions of dollars in research grants, launched a CF gene therapy company recently acquired by a large pharmaceutical company, and led worldwide efforts to drive high-impact research and drug development. The organization has been featured in national media, including the New York Times, STAT, CNN, People, and more.